HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print November 21, 2005

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0605313v1 79/2/397    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cherla, R. P. Articles by Tesh, V. L. Search for Related Content PubMed PubMed Citation Articles by Cherla, R. P. Articles by Tesh, V. L.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0605313

Received for publication June 13, 2005.
Revised October 6, 2005.
Accepted for publication October 10, 2005.

Article

Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line

Department of Medical Microbiology and Immunology, Texas A&M University System Health Science Center, College Station

^@ To whom correspondence should be addressed. E-mail: tesh{at}medicine.tamhsc.edu.

	Abstract

Upon binding to the glycolipid receptor globotriaosylceramide, Shiga toxins (Stxs) undergo retrograde transport to reach ribosomes, cleave 28S rRNA, and inhibit protein synthesis. Stxs induce the ribotoxic stress response and cytokine and chemokine expression in some cell types. Signaling mechanisms necessary for cytokine expression in the face of toxin-mediated protein synthesis inhibition are not well characterized. Stxs may regulate cytokine expression via multiple mechanisms involving increased gene transcription, mRNA transcript stabilization, and/or increased translation initiation efficiency. We show that treatment of differentiated THP-1 cells with purified Stx1 resulted in prolonged activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) cascades, and lipopolysaccharides (LPS) rapidly triggered transient activation of JNK and p38 and prolonged activation of extracellular signal-regulated kinase cascades. Simultaneous treatment with Stx1 + LPS mediated prolonged p38 MAPK activation. Stx1 increased translation eukaryotic initiation factor 4E (eIF4E) activation by 4.3-fold within 4-6 h, and LPS or Stx1 + LPS treatment increased eIF4E activation by 7.8- and 11-fold, respectively, within 1 h. eIF4E activation required Stx1 enzymatic activity and was mediated by anisomycin, another ribotoxic stress inducer. A combination of MAPK inhibitors or a MAPK-interacting kinase 1 (Mnk1)-specific inhibitor blocked eIF4E activation by all stimulants. Mnk1 inhibition blocked the transient increase in total protein synthesis detected in Stx1-treated cells but failed to block long-term protein synthesis inhibition. The MAPK inhibitors or Mnk1 inhibitor blocked soluble interleukin (IL)-1 and IL-8 production or release by 73-96%. These data suggest that Stxs may regulate cytokine expression in part through activation of MAPK cascades, activation of Mnk1, and phosphorylation of eIF4E.

Key Words: interleukin-1 • interleukin-8 • ribotoxic stress response

This article has been cited by other articles:

				K. A. D. Sauter, A. R. Melton-Celsa, K. Larkin, M. L. Troxell, A. D. O'Brien, and B. E. Magun Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody Infect. Immun., October 1, 2008; 76(10): 4469 - 4478. [Abstract] [Full Text] [PDF]

				H. K. Bae and J. J. Pestka Deoxynivalenol Induces p38 Interaction with the Ribosome in Monocytes and Macrophages Toxicol. Sci., September 1, 2008; 105(1): 59 - 66. [Abstract] [Full Text] [PDF]

				C. Zanchi, C. Zoja, M. Morigi, F. Valsecchi, X. Y. Liu, D. Rottoli, M. Locatelli, S. Buelli, A. Pezzotta, P. Mapelli, et al. Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin J. Immunol., July 15, 2008; 181(2): 1460 - 1469. [Abstract] [Full Text] [PDF]

				M. K. Stone, G. L. Kolling, M. H. Lindner, and T. G. Obrig p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and Tumor Necrosis Factor Alpha Induction of Shiga Toxin 2 Sensitivity in Human Umbilical Vein Endothelial Cells Infect. Immun., March 1, 2008; 76(3): 1115 - 1121. [Abstract] [Full Text] [PDF]

				M. Brigotti, D. Carnicelli, E. Ravanelli, A. G. Vara, C. Martinelli, R. R. Alfieri, P. G. Petronini, and P. Sestili Molecular Damage and Induction of Proinflammatory Cytokines in Human Endothelial Cells Exposed to Shiga Toxin 1, Shiga Toxin 2, and {alpha}-Sarcin Infect. Immun., May 1, 2007; 75(5): 2201 - 2207. [Abstract] [Full Text] [PDF]

				S.-Y. Lee, R. P. Cherla, and V. L. Tesh Simultaneous Induction of Apoptotic and Survival Signaling Pathways in Macrophage-Like THP-1 Cells by Shiga Toxin 1 Infect. Immun., March 1, 2007; 75(3): 1291 - 1302. [Abstract] [Full Text] [PDF]

				J. Pestka and H.-R. Zhou Toll-Like Receptor Priming Sensitizes Macrophages to Proinflammatory Cytokine Gene Induction by Deoxynivalenol and Other Toxicants Toxicol. Sci., August 1, 2006; 92(2): 445 - 455. [Abstract] [Full Text] [PDF]